References
- Wells AW, Bown N, Reid MM, et al. Erythroleukaemia in the north of England: a population based study. J Clin Pathol 2001;54:608–612.
- Hasserjian RP, Zuo Z, Garcia C, et al. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification. Blood 2010;115:1985–1992.
- Santos FP, Faderl S, Garcia-Manero G, et al. Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution. Leukemia 2009;23:2275–2280.
- Wu D, Wu Q, He G, et al. A case of acute erythroleukemia evolved from myelodysplastic syndrome with acquisition of Ph chromosome and review of the literature. Leuk Res 2011;35:837–839.
- Matthews W, Jordan CT, Wiegand GW, et al. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell enriched populations. Cell 1991;65:1143–1152.
- Robertson SC, Tynan JA, Donoghue DJ. RTK mutations and human syndromes. Trends Genet 2000;16:265–271.
- Bacher U, Haferlach C, Kern W, et al. Prognostic relevance of FLT3-TKD mutations in AML: the combination matter—an analysis of 3082 patients. Blood 2008;111:2527–2537.
- Tenen, Daniel G. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer 2003;3:89–101.
- Look AT. Oncogenic transcription factors in the human acute leukemias. Science 1997;278:1059–1064.
- Cilloni D, Saglio G. Molecular pathways: BCR-ABL. Clin Cancer Res 2012;18:930–937.
- Gordon MY, Goldman JM. Cellular and molecular mechanisms in chronic myeloid leukaemia: biology and treatment. Br J Haematol 1996;95:10–20.
- Lavagna-Sevenier C, Marchetto S, Birnbaum D, et al. FLT3 signaling in hematopoietic cells involves CBL, SHC and an unknown P115 as prominent tyrosine-phosphorylated substrates. Leukemia 1998;12:301–310.